Charles R. Drew University of Medicine and Science is a private historically black graduate school in Willowbrook, California. It was founded in 1966 in response to inadequate medical access within the Watts region of Los Angeles, California. The university is named in honor of Charles R. Drew.

During the past decade, Charles Drew University of Medicine and Science conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 9 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Charles Drew University of Medicine and Science" #1 sponsor was "Charles Drew University of Medicine and Science" with 30 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials sponsored, "Pharmacia and Upjohn" with 3 trials sponsored, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 2 trials sponsored and "Brigham and Women's Hospital" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charles Drew University of Medicine and Science" #1 collaborator was "National Center for Research Resources (NCRR)" with 4 trials as a collaborator, "University of California, Los Angeles" with 4 trials as a collaborator, "National Institute on Minority Health and Health Disparities (NIMHD)" with 3 trials as a collaborator, "American Diabetes Association" with 2 trials as a collaborator and "Los Angeles County Department of Public Health" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Charles Drew University of Medicine and Science" are "HIV Infections" (7 trials), "Type 2 Diabetes Mellitus" (5 trials), "HIV" (3 trials), "Insulin Resistance" (3 trials) and "Cancer" (2 trials). Many other conditions were trialed in "Charles Drew University of Medicine and Science" in a lesser frequency.

Most popular intervention types in "Charles Drew University of Medicine and Science" are "Drug" (23 trials), "Behavioral" (15 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Delavirdine mesylate" (2 trials), "Zidovudine" (2 trials), "1- Insulin glargine QHS" (1 trials) and "2 - Insulin glargine QAM" (1 trials). Other intervention names were less common.

The vast majority of trials in "Charles Drew University of Medicine and Science" are 32 trials for "All" genders, 7 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Charles Drew University of Medicine and Science". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Charles Drew University of Medicine and Science, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Charles Drew University of Medicine and Science, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 19 trials that are defined as “Not Applicable".